The Next Generation of Clinical Decision Making Tools: Development of a Real-Time Prediction Tool for Outcome of Prostate Biopsy in Response to a Continuously Evolving Prostate Cancer Landscape.
about
Precision Medicine in Active Surveillance for Prostate Cancer: Development of the Canary-Early Detection Research Network Active Surveillance Biopsy Risk CalculatorIs the endoscopic third ventriculostomy success score an appropriate tool to inform clinical decision-making?European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators significantly outperform the Prostate Cancer Prevention Trial (PCPT) 2.0 in the prediction of prostate cancer: a multi-institutional study.Next-generation prostate cancer risk calculator for primary care physicians.
P2860
The Next Generation of Clinical Decision Making Tools: Development of a Real-Time Prediction Tool for Outcome of Prostate Biopsy in Response to a Continuously Evolving Prostate Cancer Landscape.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The Next Generation of Clinica ...... ing Prostate Cancer Landscape.
@ast
The Next Generation of Clinica ...... ing Prostate Cancer Landscape.
@en
type
label
The Next Generation of Clinica ...... ing Prostate Cancer Landscape.
@ast
The Next Generation of Clinica ...... ing Prostate Cancer Landscape.
@en
prefLabel
The Next Generation of Clinica ...... ing Prostate Cancer Landscape.
@ast
The Next Generation of Clinica ...... ing Prostate Cancer Landscape.
@en
P2860
P1476
The Next Generation of Clinica ...... ing Prostate Cancer Landscape.
@en
P2093
Andreas N Strobl
Ian M Thompson
P2860
P356
10.1016/J.JURO.2015.01.092
P407
P577
2015-01-28T00:00:00Z